In contrast, the ESAT-6– and CFP-10–stimulated PBMCs of progressors produced less IFN-γ, IL-17, and IL-1α compared with the stimulated PBMCs of the nonprogressors at follow-up (when the progressors developed active TB). The gene discussed is IL17A; the disease is tuberculosis.